Dr. Peter Rowe talks about his new book on orthostatic intolerance and how treating it can help people with chronic fatigue syndrome (ME/CFS), POTS, Long COVID, chronic pelvic pain and other conditions.
The RECOVER Initiative focused on low risk low reward clinical trials for long COVID. Here are some possibilities that could have made a real difference. .
Ivabradine appears to work quite well in POTS – but should we stop there? Ivabradine was approved for use in the European Union in 2005, but it’s pretty new to the scene in the U.S. It was FDA approved in only 2015. That means it doesn’t have much...
A riff on Dr. Peter Rowe’s presentation at the 2020 Dysautonomia International Conference (note that I expand on many of Rowe’s points; i.e. not all the words are his.) Lauren Stiles, the founder of Dysautonomia International, has long believed that the...
Not satisfied with how your treatments for fibromyalgia and/or chronic fatigue syndrome (ME/CFS) is going? Look to the future at the drugs trials underway in both these diseases as well as other trials in other diseases that may help.
Keep the information flowing! Support Health Rising during our end of the year fundraising drive. Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.